ISB News

We Study Microbes Because It’s Good for Your Health

Here’s a piece adapted from Michael Pollan’s latest book “Cooked: A Natural History of Transformation” which discusses how processed foods and the modern diet have made us more obese and more likely to get sick. He makes a case for eating more fermented foods that haven’t been pasteurized – probiotics, live-culture foods – in order to get the good bacteria back in our guts.

At ISB, the microbiome is an area of focus because microbes play such a huge role not only in humans but in the environment, too. Our annual symposium in 2012 centered on the microbiome (read ISB founder Dr. Lee Hood’s editorial “Tackling the Microbiome”) and brought some of the world’s experts in the field to share the latest research.

Read Michael Pollan’s piece

 

 

 

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.